Zota Health Care Ltd. · NSE:ZOTA
Zota Health Care — Q2 FY26 Earnings Presentation
46 slides from Zota Health Care's earnings presentation, Oct 19, 2025
Slide 1: Regulation 30 submission letter to NSE
October 19, 2025 To, The Manager Listing Department, The National Stock Exchange of India Limited Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai – 400051 Dear Sir/Madam, Trading Symbol: ZOTA Sub: Investor Presentation Ref: Regulation 30 of SEBI (Listing Obligations and Disclosure Requireme
Slide 2: Investor Presentation Q2FY26
Investor Presentation Zota Health Care Limited Q2FY26
Slide 3: Safe Harbour
This presentation has been prepared by the Zota Health Care Limited (the “Company”) Safe Harbour only for information purpose to the stakeholders and does not contain any offer or invitation to subscribe the securities of the Company. No offering of securities shall be made except by means of offer
Slide 4: Company Overview
healthcare Itd. Company Overview A zota healthcare Itd.
Slide 5: Zota Healthcare At a Glance
Zota Healthcare At a Glance Financial Highlights (FY25 - Consolidated) Zota Health Care Ltd., a Headquartered in Surat and Davaindia, launched in 2017, The strategic business model publicly listed company on employing dedicated is a retail generic pharmacy allows Davaindia to be both NSE, has establ
Slide 6: Our Journey
Our Journey Foundational Steps In Setting Up Formulations Domestic Marketing Export Business Strengthening Core And Pioneering Davaindia 2000 2004 2010 2011 2017 2018 Zota Health Care - Acquired all brand Inaugurated an export- Commenced exports, Introduced Davaindia, a Achieved ₹10+ Cr in Export Sa
Slide 7: Management Profile
Management Profile K e t a nk u m a r Z o t a Moxesh Zota Sujit Paul Chairman And Managing Director Group Chief Executive Officer Non-executive Director Total Experience: 38+ Total Experience: 10+ Total Experience: 23+ • Holds a D-Pharmacy degree • Holds a Bachelor’s degree in pharmacy & • Featured
Slide 8: Company Structure
Company Structure Step down subsidiary Supplying products at ALP* Davaindia Zota Health Care Limited (Listed entity) (Davaindia Health Mart Limited) Procurement in listed entity FOFO Domestic Export COCO (Sales to FOFO# stores) (COCO# stores) FOFO Sales through COCO Sales through Zota Health Care Da
Slide 9: Business Overview
healthcare Itd. Business Overview A zota healthcare Itd.
Slide 10: Business Verticals
Business Verticals DAVAINDIA Revenue contribution (Q2FY26) • A Retail generic pharmacy chain providing quality generic medicines. • Focuses only on private-label products in: 02 Store variants 30% – 90% Company Owned Company Operated Savings on medicines as Everday Herbal Group • Medicinal | OTC | A
Slide 11: Case Study – Savings on Davaindia margins
Case Study – Savings on Davaindia margins Company marketed by > Indian Pharma MNC 1 Indian Pharma MNC 2 Davaindia Same Tablet with Significant Tablet / Medicine Name Rosuvas – 10 mg Rosubest - 10 Rosuvastatin 10 same molecule savings in margins Molecule Rosuvastatin 10mg Generic Type Branded Generic
Slide 12: DAVAINDIA
d davaindia’ GENERIC PHARMACY DAVAINDIA
Slide 13: Davaindia - Retail Pharmacy Chain data
Davaindia - Retail Pharmacy Chain data Revolutionizing the generic pharmacy industry with affordable, accessible, quality healthcare solutions through retail pharmacies’ chain. 2000+ 2,055* 1,207 848 Total no. COCO stores FOFO Stores SKUs of stores *As of 30th September 2025 • Launched in 2017, Dava
Slide 14: Davaindia - Operating Model
Davaindia - Operating Model Davaindia Health Mart Limited has Offers a cluster-based store 2,000+ SKUs with 70% medicinal Cloud-based software and AI- implemented a hyperlocal e-commerce model model, optimizing accessibility products and 30% OTC products, with based tools for real-time supply for on
Slide 15: Davaindia - Eliminating traditional supply chain
Davaindia - Eliminating traditional supply chain By sourcing directly from manufacturers and selling straight to consumers, traditional pharma supply chain is eliminated & the cost benefits are transferred to the consumer Average consumer price ~75% savings Doctors on Davaindia medicines as compared
Slide 16: Strengthening the Visibility
Strengthening the Visibility Zota Group Welcomes Mr. Mahendra Singh Dhoni & Mr. Suniel Shetty as Brand Ambassador of Davaindia 15
Slide 17: Davaindia – What are COCO Stores
Davaindia – What are COCO Stores COCO stores are modern walk-in stores providing a distinct contrast to traditional counter-based pharmacies enhancing customer satisfaction and loyalty. Rapid Expansion The timeline for launching a new COCO store has been significantly shortened, enabling faster roll
Slide 18: Davaindia – COCO Stores
Davaindia – COCO Stores 17
Slide 19: Davaindia - COCO Stores
Davaindia - COCO Stores Company-Owned Company-Operated 1,207 States No. of Stores Operational West Bengal Operated by wholly-owned 388 subsidiary 12 COCO stores Uttar Pradesh Davaindia Health Mart Ltd 229 22 51 Maharashtra 116 64 Enhancing Store Delhi 87 87 Economics Odisha 2 Haryana 64 47 229 Gujar
Slide 20: Davaindia COCO - KPI's (1/2)
Davaindia COCO - KPI’s (1/2) No. of Stores Quarterly Footfall in lakhs 1,207 29.6 986 23.0 852 19.0 658 15.7 494 11.8 Q2 FY25 Q3FY25 Q4FY25 Q1FY26 Q2FY26 Q2 FY25 Q3 FY25 Q4FY25 Q1FY26 Q2FY26 19
Slide 21: Davaindia COCO - KPI's (2/2)
Davaindia COCO - KPI’s (2/2) Quarterly GMV ₹ lakhs Avg. Wallet Spend ₹ ₹ 6,780 ₹ 229 ₹ 231 ₹ 229 ₹ 224 ₹ 227 ₹ 5,290 ₹ 4,297 ₹ 3,507 ₹ 2,714 Q2 FY25 Q3 FY25 Q4FY25 Q1FY26 Q2FY26 Q2 FY25 Q3 FY25 Q4FY25 Q1FY26 Q2FY26 20
Slide 22: Same Store Growth Performance: Period Wise Analysis
Same Store Growth Performance: Period Wise Analysis (852 Store – Till March 2025) GMV in ₹lakhs/Month 7.02 6.65 5.52 4.63 4.27 3.67 3.23 2.94 2.58 2.30 2.33 1.98 2.13 1.97 1.59 1.6 1.70 1.31 1.28 1.14 3+ Months 6+ Months 9+ Months 12+ Months 15+ Months 18 to 24 Months 24 to 30 Months 36 to 48 Months
Slide 23: Davaindia – What are FOFO Stores
Davaindia – What are FOFO Stores Franchisee-Owned Franchisee-Operated Asset-light franchise model (FOFO) FOFO stores employ an asset-light franchise model, contributing to the scalability and accessibility of our product offerings. Smaller Store size FOFO stores are compact and over-the-counter form
Slide 24: Davaindia - FOFO Stores
Davaindia - FOFO Stores States No. of Stores West Bengal 164 13 Uttar Pradesh 167 Maharashtra 43 2 Delhi 30 6 12 Odisha 112 42 3 Haryana 42 30 Gujarat 57 1 Madhya Pradesh 65 28 9 848 167 Kerala 16 26 Rajasthan 28 Uttarakhand 12 15 57 65 9 164 Operational FOFO stores Telangana 4 Karnataka 9 1 Punjab
Slide 25: Davaindia FOFO - KPI's (1/2)
Davaindia FOFO - KPI’s (1/2) No. of Stores Quarterly Footfall 848 759 13.9 730 697 12.4 664 11.9 11.3 10.4 Q2 FY25 Q3 FY25 Q4FY25 Q1FY26 Q2FY26 Q2 FY25 Q3 FY25 Q4 FY25 Q1 FY26 Q2 FY26 24
Slide 26: Davaindia FOFO - KPI's (2/2)
Davaindia FOFO - KPI’s (2/2) Quarterly GMV ₹ lakhs Avg. Wallet Spend ₹ 285 ₹ 3,923 ₹ 3,385 ₹ 3,488 ₹ 282 ₹ 3,161 ₹ 281 ₹ 2,840 ₹ 279 ₹ 274 Q2 FY25 Q3 FY25 Q4 FY25 Q1 FY26 Q2 FY26 Q2 FY25 Q3 FY25 Q4 FY25 Q1 FY26 Q2 FY26 25
Slide 27: OTC Revenue contribution and Everyday Herbal acquisition
OTC Over-the-counter products Strategic Acquisition as a Acquired 65.98% stake in the Everyday Herbal Group*, move towards backward licensed by the Khadi and Village Industrial Commission, a integration strategic move towards backward integration. OTC products make up ~30% of the stock keeping units
Slide 28: OTC – Products
OTC – Products 27
Slide 29: Davaindia is Revolutionising the Indian Healthcare Scenario
Davaindia is Revolutionising the Indian Healthcare Scenario ₹10,703 lacs ~60 % Gross Merchandise Value in Q2FY26 Gross Margin in COCO format 2,055 30-90 % Savings to consumers on Fast growing FOFO & Generic medicines COCO store network* *As on 30th September 2025 25-30 % Mature COCO Stores EBITDA# #
Slide 30: State-Wise Presence of Davaindia Across India
State-Wise Presence of Davaindia Across India (COCO & FOFO Models) States COCO FOFO Total West Bengal 388 164 552 Uttar Pradesh 229 167 396 Maharashtra 116 43 159 Delhi 87 30 117 Odisha 2 112 114 Haryana 64 42 106 Gujarat 29 57 86 Madhya Pradesh 14 65 79 Kerala 63 16 79 Rajasthan 47 28 75 Uttarakhan
Slide 31: Davaindia Competitive Edge
Davaindia Competitive Edge The USP of Davaindia: Affordable, Trustworthy, and Innovative Pharmacy Solutions BENEFITS TO THE CUSTOMERS BENEFITS TO THE FRANCHISEES Medicines priced at low MRP thereby ensuring affordability for the masses Store operations and the supply chain efficiently managed by clo
Slide 32: Healthy Repeats
Healthy Repeats Total Average (in %) With a strong base of 80% repeat customers, Davaindia demonstrates a high level of customer satisfaction 80% and loyalty. Repeat Customers 12% New Customers 08% Lost Customers 31
Slide 33: Higher Chronic category share
Higher Click toChronic edit Master category title share style CATEGORY MIX FY25 CATEGORY MIX Q2FY26 57% 60% 27% 27% 16% 13% Chronic OTC Other Chronic OTC Other Higher chronic share: A significant 60% of our revenue comes from chronic disease category, signalling high realization and retention rates,
Slide 34: Supply Chain Management
Click Supply to edit ChainMaster Management title style • The Company has outsourced supply chain management to a third-party warehousing & logistics partner. • A state-of-art central warehousing & processing center has been built in Surat, in Phase 1. • Eventually the Company will replicate such in
Slide 35: Domestic Operations
healthcare Itd. Domestic Operations A zota healthcare Itd.
Slide 36: Domestic Operations
Domestic Operations Marketing Value Chain: Domestic marketing has been the oldest business vertical for the FDF Manufacturers Company and has remained its mainstay in the past. Until 2017, WHO-GMP certified this vertical contributed most of the Company’s revenues. This manufacturing partners busines
Slide 37: Export Operations
healthcare Itd. Export Operations A zota healthcare Itd.
Slide 38: Export Operations
Export Operations Dossiers Registered In Global Markets Our Exports business vertical, which started in 2010, serves 1. Benin 15. Sri Lanka clients in over 30 countries, mainly in the CIS, Latin America, 2. Bolivia 16. Swaziland Africa, and Asia. At its plant in Sachin, SEZ, the Company 3. Cambodia
Slide 39: Financial Overview
healthcare Itd. Financial Overview A zota healthcare Itd.
Slide 40: Management Commentary
Management Commentary “We are pleased to report another strong quarter driven by robust operational execution and strategic expansion taking our total store count to 2,055. This includes 1,207 COCO and 848 FOFO outlets as on 30th September 2025. The rapid expansion, especially in COCO format, is not
Slide 41: Quarterly Revenue Segmentation
Quarterly Revenue Segmentation Business Verticals – Consolidated Revenue bifurcation Davaindia ₹ lakhs Domestic Operations ₹ lakhs Export Operations ₹ lakhs Everyday Herbal ₹ lakhs 1,791 624 9,559 1,587 1,507 1,095 7,563 451 655 664 4,260 226 Q2 FY25 Q1 FY26 Q2 FY26 Q2 FY25 Q1 FY26 Q2 FY26 Q2 FY25 Q
Slide 42: Annually Financial Snapshot
Annually Financial Snapshot Davaindia ₹ lakhs Domestic Operations ₹ lakhs Export Operations ₹ lakhs 18,621 6,342 3,190 17,122 5,983 5,950 3,014 5,689 2,467 2,004 10,356 1,759 3,297 5,578 4,122 FY22 FY23 FY24 FY25 H1FY26 FY22 FY23 FY24 FY25 H1FY26 FY22 FY23 FY24 FY25 H1FY26 Davaindia has driven reven
Slide 43: Business Vertical Performance (Consolidated)
Business Vertical Performance (Consolidated) ₹ in lakhs (Consolidated) Q2 FY26 Particulars Business Vertical Consolidated Davaindia Domestic Exports Everyday Revenue from Operation 9558.6 1790.5 1095.0 450.8 12894.8 Cost of Goods Sold 3230.1 1190.7 476.3 347.5 5244.6 Gross Profit 6328.5 599.8 618.7
Slide 44: Profit & Loss Statement (Consolidated)
Profit & Loss Statement (Consolidated) ₹ in lakhs (Consolidated) Particulars Q2FY26 Q1FY26 Q2FY25 H1FY26 H1FY25 FY25 Export Sales (SEZ) 1095.0 664.2 654.7 1759.2 1126.8 3190.3 Davaindia Sales 9558.6 7562.9 4260.4 17121.5 7841.3 18621.4 Domestic Sales 1790.5 1506.9 1586.5 3297.4 2977.4 6341.5 Everyda
Slide 45: Balance Sheet Statement (Consolidated)
Balance Sheet Statement (Consolidated) ₹ in lakhs (Consolidated) As at As at As at As at Assets Equity and Liabilities 30th September 2025 31st March 2025 30th September 2025 31st March 2025 Non-Current Assets (i) Equity Share capital 3,064.4 2,863.5 Property, plant and equipment 7,593.5 5,598.9 (ii
Slide 46: Thank You
Thank You "ZOTA HOUSE", 2/896, Hira Modi Street, Siddesh Chawan - Sagrampura, -Surat-395 002 (Gujarat) siddesh.chawan@in.ey.com Ajit Mishra - cszota@zotahealthcare.com ajit.j.mishra@in.ey.com www.zotahealthcare.com 45